CARL vs XOM · rev $50.5M vs P/E 24, rev $201.16B
Carlsmed, Inc. Common Stock (CARL) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE.
Latest reported CARL revenue for 2025-12-31 was $50.5M. Net income was -$29.6M. Revenue was up 85.9% from 2024-12-31 to 2025-12-31. CARL currently screens at market cap $299.7M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CARL currently screens at market cap $299.7M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CARL and XOM stock pages for the full models.
Not investment advice.